| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Med Help International is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Melbourne, FL. To find more information about Med Help International, please visit www.medhelp.org
NEO U is a live streaming and on demand platform for trainers and brands to scale to a world-wide audience. We host top fitness experts and workout concepts from around the world in our state-of-the-art fitness hub in Midtown Manhattan.
Surveillance Data is a Morrisville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Travis County Medical Society is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.